| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2259 | 2019 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 532 | 2019 |
| Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure M Komajda, M Böhm, J Borer, I Ford, H Krum, A Tase, L Tavazzi, ... European journal of heart failure 15 (1), 79-84, 2013 | 41 | 2013 |
| Cercetări comparative asupra eficienţei terapeutice a unor inhibitori ai enzimei de conversie a angiotensinei A Tase Editura Universităţii din Piteşti, 2007 | 7 | 2007 |
| Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry M Kerneis, F Cosentino, R Ferrari, JL Georges, E Kosmachova, ... European journal of preventive cardiology 29 (15), 1945-1954, 2022 | 6 | 2022 |
| The ESC-EORP Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry M Komajda, F Cosentino, R Ferrari, C Laroche, A Maggioni, PG Steg, ... European Heart Journal-Quality of Care and Clinical Outcomes 7 (1), 28-33, 2021 | 4 | 2021 |
| Health promotion and disease prevention A Tase, L Titu | 4 | |
| HMG-CoA-reductase inhibitor co-therapy lowers the risk for incident heart failure in farmorubicin recipients for two cancer locations AG Tase, A Tase, O Tetiu, G Savoiu, G Stanciulescu, M Mihaila European Heart Journal 34 (suppl_1), 141, 2013 | 3 | 2013 |
| Spironolactone added-on standard antiarrhytmic pharmacological therapy decreases the atrial fibrillation recurrences A Tase, M Popescu, M Tantu Acta Medica Transilvanica 19 (3), 203-205, 2014 | 2 | 2014 |
| Vârsta, factorii de risc cardiovascular, terapia şi mortalitatea intraspitalicească la pacienţii cu infarct miocardic acut cu supradenivelare de segment ST. Un subraport al … D Ţînţ, M Rădoi, A Petriş, DM Datcu, C Sinescu, E Craiu, D Vinereanu, ... Romanian Journal of Cardiology| Vol 26 (1), 2011 | 2 | 2011 |
| Trimetazidine added-on therapy could lower the risk of incidental left ventricular dysfunction with or without heart failure in epirubicinum recipients for breast cancer AG Tase, MG Man, A Tase, G Savoiu Journal of the American College of Cardiology 69 (11S), 917-917, 2017 | 1 | 2017 |
| Uninterrupted ivabradine treatment may provide lasting reduction of persistent sinus tachycardia with preserved airways physiology in lung cancer patients: a 48 months … AG Tase, G Savoiu, OT Tetiu, A Tase, MG Man, G Stanciulescu, M Mihaila, ... EUROPEAN HEART JOURNAL 37, 41-41, 2016 | 1 | 2016 |
| Add-On therapy with hmg-coa-reductase inhibitors may lower the risk for incident left ventricular dysfunction+/− heart failure in epirubicin recipients with gastric cancer A Tase, OT Titus, A Tase, G Savoiu, I Iorga-Siman, M Mihaila Journal of the American College of Cardiology 63 (12S), A932-A932, 2014 | 1 | 2014 |
| DNA modification and cancer-spectral study of bleomycin-DNA interaction LE Vijan, A Tase REVISTA DE CHIMIE-BUCHAREST-ORIGINAL EDITION- 58 (7), 628, 2007 | 1 | 2007 |
| The self-association of bleomycin-a chemical basis for superior pharmacokinetics LE Vijan, A Tase REVISTA DE CHIMIE-BUCHAREST-ORIGINAL EDITION- 58 (2), 199, 2007 | 1 | 2007 |
| Management competitiv medical A Tase, A Tase Editura Universităţii din Piteşti, 2002 | 1 | 2002 |
| A medical impact of war: the hypertension crises dynamic in an adjacent population A Tase, C Stefan, L Stanciulescu, FC Calina, M Tantu European Heart Journal 44 (Supplement_2), ehad655. 2328, 2023 | | 2023 |
| Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction plus/-heart failure in epirubicinum recipients for bladder cancer AG Tase, MG Man, A Tase, G Savoiu, GE Stanciulescu, I Iorga-Siman EUROPEAN HEART JOURNAL 38, 899-899, 2017 | | 2017 |
| P4355 Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction+/− heart failure in epirubicinum recipients for bladder cancer AG Tase, MG Man, A Tase, G Savoiu, GE Stanciulescu, I Iorga-Siman European Heart Journal 38 (suppl_1), ehx504. P4355, 2017 | | 2017 |
| The role of betablockers in lowering the risk of chemotherapy-induced heart failure in breast cancer A Tase Current Trends in Natural Sciences Vol 4 (7), 75-81, 2015 | | 2015 |
